Foamix is a specialty pharmaceutical company working to solve some of today's most difficult therapeutic challenges in dermatology and beyond. With expertise in topical medicine innovation as a springboard, the Company is working to develop and commercialize solutions that were long thought impossible, including the world's first topical minocycline, AMZEEQ™. Its proprietary Molecule Stabilizing Technology (MST™) is utilized in the Company's dermatology products and in other products currently in development: FMX103 for the potential treatment of moderate to severe papulopustular rosacea and FCD105 for the potential treatment of moderate to severe acne. Foamix is a different type of specialty pharmaceutical company by design, driven to see the solutions, overcome barriers in all aspects of business, and reimagine what's possible for conditions with high unmet needs. Foamix uses its website as a channel to distribute information about Foamix and its product candidates from time to time. Foamix may use its website to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Foamix's website in addition to following its press releases, filings with the Securities and Exchange Commission, public conference calls, and webcasts.
View Top Employees from Foamix Pharmaceuticals Ltd.Website | http://foamix.com |
Ticker | FOMX |
Revenue | $3 million |
Funding | $64 million |
Employees | View employees |
Address | 2 Holzman St Weizmann Science Park, Rehovot, Central District, IL |
Phone | +972 8-931-6233 |
Fax | +972 8-947-4356 |
Industry | Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
Competitors | Cytochroma Inc., PolyPid Ltd., Presidio Pharmaceuticals, Inc., QUEST PHARMA LIMITED, UroGen Pharma (formerly TheraCoat) |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325412 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Foamix Pharmaceuticals Ltd. employee's phone or email?
The Foamix Pharmaceuticals Ltd. annual revenue was $3 million in 2023.
Foamix Pharmaceuticals Ltd. is based in Rehovot, Central District.
The NAICS codes for Foamix Pharmaceuticals Ltd. are [325412, 32541, 3254, 32, 325].
The SIC codes for Foamix Pharmaceuticals Ltd. are [283, 28].